Bromoacetyl bromide → 1-(2-benzyloxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-bromo-ethanone
반응식
[CH2:1]([O:8][C:9]1[CH:17]=[C:12]2[CH2:13][NH:14][CH2:15][CH2:16][N:11]2[N:10]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[Br:18][CH2:19][C:20](Br)=[O:21]>C(Cl)Cl>[CH2:1]([O:8][C:9]1[CH:17]=[C:12]2[CH2:13][N:14]([C:20](=[O:21])[CH2:19][Br:18])[CH2:15][CH2:16][N:11]2[N:10]=1)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1참가 물질
4
실험 절차
A solution of 2-(benzyloxy)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine (0.02 g, 0.087 mmol) in a DCM (1 mL) was treated with bromoacetyl bromide (7.6 μL, 17.6 mg, 0.087 mmol) at 0° C. The solvents were evaporated in vacuo to yield 1-(2-benzyloxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-2-bromo-ethanone as a white solid, that was used in the next step without further purification.
후처리
- customThe solvents were evaporated in vacuo
출처 및 근거
- ORD 기록
- ord-8177760a94774f5fa09f57182d8e0aaf
- 출처 데이터셋
- uspto-grants-2015_05
- 특허 번호
- US09029366B2
반응 노트
불러오는 중…